New human data suggest psilocybin may reduce inflammation and mitochondrial stress in Parkinson's patients, with benefits persisting a month after treatment. Though the small pilot study lacked controls, researchers call the biological signals promising for neurodegenerative and inflammatory conditions.
Psilocybin Shows Early Promise Against Body-Wide Inflammation
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →